Fulcrum Therapeutics Inc
Research Fulcrum Therapeutics Inc (FULC) on Bullrun: market cap USD 248.54M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFULC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 248.54M
- Financial periodFY2025
- Revenue growth-100.0%
- Net income-USD 74.88M
- Free cash flow-USD 60.38M
Valuation Snapshot
latest market cap is USD 248.54M.
About Fulcrum Therapeutics Inc
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia.
Frequently asked questions
What is Fulcrum Therapeutics Inc's market cap?
Fulcrum Therapeutics Inc's market capitalization is USD 248.54M.
What does Fulcrum Therapeutics Inc do?
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States.